Brookstone Capital Management Purchases 3,304 Shares of Intuitive Surgical, Inc. $ISRG

Brookstone Capital Management boosted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 15.4% during the 2nd quarter, Holdings Channel reports. The fund owned 24,693 shares of the medical equipment provider’s stock after buying an additional 3,304 shares during the period. Brookstone Capital Management’s holdings in Intuitive Surgical were worth $13,418,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. Jacobsen Capital Management boosted its holdings in Intuitive Surgical by 6.4% in the second quarter. Jacobsen Capital Management now owns 615 shares of the medical equipment provider’s stock worth $334,000 after acquiring an additional 37 shares in the last quarter. D.A. Davidson & CO. raised its stake in shares of Intuitive Surgical by 2.5% in the second quarter. D.A. Davidson & CO. now owns 13,863 shares of the medical equipment provider’s stock worth $7,533,000 after purchasing an additional 339 shares during the last quarter. Cullen Frost Bankers Inc. raised its stake in shares of Intuitive Surgical by 1.6% in the second quarter. Cullen Frost Bankers Inc. now owns 78,606 shares of the medical equipment provider’s stock worth $42,715,000 after purchasing an additional 1,224 shares during the last quarter. Smith Thornton Advisors LLC purchased a new stake in shares of Intuitive Surgical in the second quarter worth approximately $411,000. Finally, Whittier Trust Co. of Nevada Inc. raised its stake in shares of Intuitive Surgical by 30.5% in the second quarter. Whittier Trust Co. of Nevada Inc. now owns 45,129 shares of the medical equipment provider’s stock worth $24,523,000 after purchasing an additional 10,555 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In other news, insider Gary S. Guthart sold 29,360 shares of the firm’s stock in a transaction on Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the transaction, the insider directly owned 19,827 shares of the company’s stock, valued at $9,368,059.23. This trade represents a 59.69% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Amy L. Ladd sold 336 shares of the firm’s stock in a transaction on Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total value of $157,956.96. Following the completion of the transaction, the director directly owned 1,074 shares of the company’s stock, valued at $504,898.14. The trade was a 23.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 45,224 shares of company stock valued at $21,716,492 over the last three months. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Trading Up 13.9%

Shares of ISRG opened at $527.03 on Thursday. The company has a market capitalization of $188.93 billion, a price-to-earnings ratio of 69.71, a PEG ratio of 4.86 and a beta of 1.61. The stock has a 50 day moving average of $455.28 and a 200 day moving average of $495.80. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.03% and a net margin of 28.58%.The company had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. During the same period last year, the business posted $1.84 earnings per share. Intuitive Surgical’s revenue was up 22.9% on a year-over-year basis. As a group, equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Wall Street Analyst Weigh In

Several analysts have recently commented on ISRG shares. Evercore ISI lowered their price objective on Intuitive Surgical from $535.00 to $450.00 and set an “in-line” rating for the company in a research note on Tuesday, October 7th. Raymond James Financial set a $603.00 price objective on Intuitive Surgical and gave the stock an “outperform” rating in a research note on Wednesday. Sanford C. Bernstein reissued an “outperform” rating and issued a $685.00 price objective on shares of Intuitive Surgical in a research note on Tuesday. Royal Bank Of Canada set a $625.00 price objective on Intuitive Surgical and gave the stock an “outperform” rating in a research note on Wednesday. Finally, Truist Financial set a $620.00 price objective on Intuitive Surgical and gave the stock a “buy” rating in a research note on Wednesday. Sixteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $599.68.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.